Biodelivery Sciences International Stock News

Merger updates from BioDelivery (BDSI) and Seagen (SGEN) earnings results are among a few key highlights from the biotech sector during the past week.

NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: BioDelivery Sciences International, Inc. (NASDAQ: BDSI )''s sale to Collegium Pharmaceutical, Inc. for $5.60 per share. If you are a BioDelivery shareholder, click here to learn more about your rights and options . Zurn Water Solutions Corporation (NYSE: ZWS )''s merger with Elkay Manufacturing Company. If you are a Zurn Water shareholder, Full story available on Benzinga.com

Collegium (COLL) is set to acquire BioDelivery (BDSI) for approximately $604 million in cash. The transaction is likely to be completed by the end of first-quarter 2022.

Upgrades For Blue Bird Corp (NASDAQ:BLBD), Roth Capital upgraded the previous rating of Neutral to Buy. Blue Bird earned $0.07 in the first quarter, compared to $0.00 in the year-ago quarter. The stoc

Collegium (COLL) is set to acquire BioDelivery (BDSI) for approximately $604 million in cash. The transaction is likely to be completed by the end of first-quarter 2022.

EV stocks rallied following a series of Super Bowl ads. BDSI and CNR both climbed on separate deals to be acquired. DAVE lost more than a third of its value. AFRM set a new low.

Today, a big takeover announcement has sent shares of BioDelivery and BDSI stock soaring more than 50% on investor enthusiasm for this deal.

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) and BioDelivery Sciences International Inc. (NASDAQ: BDSI) have announced a definitive agreement where Collegium will acquire BDSI for USD 5.60 per share in cash. BDSI holds a portfolio of pain and neurology products that focus on serious and debilitating conditions. We are excited to announce this acquisition, which represents a major step forward in our mission to build a leading, diversified specialty pharmaceutical company committed to improving the lives of people suffering from serious medical conditions, said Joe Ciaffoni, President and Chief Executive Officer of Collegium. The BDSI portfolio expands and enhances Collegiums differentiated pain offerings and establishes a foothold in neurology, a strategic market adjacency. Importantly, we expect this acquisition will be immediately and highly accretive by expanding our revenue scale and generating significant synergies.

Gainers: BioDelivery Sciences International BDSI +52%. Knightscope KSCP +31%. Ebang International (EBON) +22%. Cornerstone Building Brands (CNR) +22%. Kelly Services KELYA +18%

US stocks remained mixed midway through trading on Monday amid rising tensions on the border of Russia and Ukraine. The United States said Russia had amassed troops on the Ukrainian border to launch an invasion, Reuters reported. The Dow traded down 0.43% to 34,588.21 while the NASDAQ rose 0.63% to 13,878.37. The S&P also fell, dropping, 0.16% to 4,411.63. Check out this: Executives Buy Around $93M Of 3 Stocks Leading and Lagging Sectors Consumer discretionary shares climbed 1.5% on Monday. Meanwhile, top gainers in the sector included Horizon Global Corporation (NYSE: HZN ), up 9% and Rivian Automotive, Inc. (NASDAQ: RIVN ) up 11%. In trading on Monday, energy shares tumbled by 2.6%. Top Headline TreeHouse Foods Inc (NYSE: THS ) reported better-than-expected earnings for its fourth quarter. TreeHouse Foods reported a fourth-quarter FY21 sales decline of 1% year-on-year, to $1.17 billion, beating the analyst consensus of $1.12 billion. Adjusted EPS of $0.11 beat the analyst consensus of $0.09.

BioDelivery Sciences Intl (NASDAQ: BDSI ) has outperformed the market over the past 5 years by 10.98% on an annualized basis. Buying $1,000 In BDSI: 5 years ago, an investor could have purchased 533.33 shares of BioDelivery Sciences Intl at the time with $1,000. This investment in BDSI would have … Full story available on Benzinga.com

Markets opened lower on Monday morning, but nothing held these two companies back.

BioDelivery Sciences International, Inc. shares reached a new 52-week high on Monday. The stock traded as high as $5.56 and last traded at $5.52, with a volume of 275687 shares

BioDelivery Sciences International, Inc. shares reached a new 52-week high on Monday. The stock traded as high as $5.56 and last traded at $5.52, with a volume of 275687 shares